Headline
The latest stories from AHA Today.
At Dell Seton Medical Center, clinicians observed that patients with opioid use disorder had a high likelihood of readmission because its underlying causes were not being addressed.
A federal district court in New York blocked the Department of Health and Human Services from revising a 2016 rule implementing nondiscrimination protections for patients under Section 1557 of the Affordable Care Act.
Michelle Hood, AHA’s executive vice president and chief operating officer, previews the association’s Sept. 14-16 virtual conference, Navigating a New Reality: Health Care Leaders Confront the Future, sponsored by the AHA Center for Health Innovation and the Society for Health Care Strategy and…
One in four U.S. counties, or 818, were COVID-19 hotspots for at least one day in the period between March 8 and July 15, representing 80% of the U.S. population, according to a report released by the Centers for Disease Control and Prevention.
The Centers for Disease Control and Prevention updated its guidance for determining when health care personnel with confirmed or suspected COVID-19 may return to work.
A test kit made by Thermo Fisher Scientific to detect COVID-19 from respiratory specimens may produce false positive results, the Food and Drug Administration warned.
The Centers for Medicare & Medicaid Services announced it will resume routine inspections of all Medicare- and Medicaid-certified providers and suppliers that were previously suspended as part of its response to the COVID-19 pandemic.
The Centers for Medicare & Medicaid Services updated its guidance related to the 20% inpatient prospective payment system diagnosis-related group rate add-on for patients diagnosed with COVID-19.
HHS delayed today’s expected release of additional details regarding data elements for providers who accepted Provider Relief Fund program funds.
FDA Saturday issued an emergency use authorization to Yale School of Public Health for a new test to detect SARS-CoV-2 in saliva.